vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidémie - Činidla modifikující lipidy - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Evropská unie -
čeština -
EMA (European Medicines Agency)